Keywords: Uterus, Uterus, Radiogenomics
Motivation: To explore genetically based molecular profiling of endometrial cancer (EC) patients to delineate prognostic risk groups.
Goal(s): To demonstrate the potential of radiogenomics for classification of EC molecular subtypes, 254 EC patients with histologically and genetically proven EC from two-center were enrolled.
Approach: A radiomics model based on four sequences was combined with genomics features to form the final diagnosed model.
Results: Our results showed a medium-to-high diagnostic performance to distinguish molecular subtypes with AUC of 0.849 and 0.673 in internal and external test sets, respectively. The radiogenomics model could guide clinicians in administering individual treatments for EC patients.
Impact: Our results demonstrate that the predictive model derived from MRI imaging features holds significant promise in identifying molecular subtypes in endometrial cancer. This model has the potential to guide clinicians in tailoring individualized treatments for EC patients.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords